Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intranasal COVID-19 vaccine in the 5 to 18 age group. On September 6, the Drugs Controller General of India (DCGI) had approved...
Wearable technology in healthcare is growing rapidly with several advanced features which are expected to offer significant advantages for pharma enterprises
Zydus Lifesciences Ltd said it has acquired rights to market MonoFerric (iron isomaltoside) injection, used to treat iron deficiency in adult patients, in India and Nepal from Denmark-based Pharmacosmos A/S...
Emergency healthcare provider CIPACA has entered into a collaboration with ImpactGuru.com to help patients living in rural areas avail of financial services for their treatment, the firm said. Chennai Interventional Pulmonology and Critical Care...
Allurion, a firm dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India - the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority..
TraceX Technologies has partnered with Liechtenstein-based CannSol. Through this collaboration with TraceX, CannSol will offer traceability of each ingredient at every stage of the production of the product...
Online pharmacy 1mg has entered the unicorn club after an internal funding round led by Tata Digital, sources briefed on the matter said...
It does not need to be said that health care resources are limited and that there are many more interventions that provide benefits to patients than society can afford.
Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to a research...
Cipla, KKR-owned JB Chemicals and Torrent Pharmaceuticals are in the final race for acquiring Medley Pharmaceuticals in a deal worth around ₹4,500 crore, said people aware of the development. Half a dozen bids were in for Medley, including bids...